Make Big Money: Think Like an Insider

Insider buying by corporate officers should be taken as optimistic visions of the future prospects of their companies and their stock prices.

Jim Cramer: With Biden the Democratic Favorite, These Stocks Are Front-Runners

These managed care stocks can withstand China, politics and a slowdown in the economy.

Cardinal Health: Waiting for History to Repeat Itself

Cardinal Health's depressed stock price may be poised for a rebound.

Allergan Stock Slips Despite Beat and Raised Guidance

Shares of the maker of Botox are struggling despite its latest results exceeding expectations.

Be a 'Goal Achieving' Investor, Not a 'Stress Relieving' One

And Cognizant Technology Solutions currently provides the former type of investor with a rare opportunity.

2 Pricey Stocks Based on Their Balance Sheets

Shares of Dunkin's Brands and Planet Fitness appear to be expensive in light of the amount of debt the companies carry.

Gilead Sciences Is Regaining Its Shine

Revenue is stabilizing with new treatment lines, and this stock may be a soon be a buy.

Teva Pharmaceuticals CEO: Stock on Track for 2020 Turnaround

But is a Teva turnaround still coming after the stock's 70% loss in the past five years?

A Review of the Regulatory Hurdles Remaining for the CVS Aetna Acquisition

Aetna's additive effects on CVS's earnings might be front and center, but it isn't fully actualized just yet.

'Medicare for All' Efforts Should Rightfully Weigh on CVS Shareholder Minds

As CVS Health's stock continues to run, management's careful approach should be encouraging for beleaguered investors.